Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
Elke BoxhammerMoritz MirnaLaura BäzNina BacherAlbert TopfBrigitte SiposMarcus FranzDaniel KretzschmarUta C HoppeAlexander LautenMichael LichtenauerPublished in: Life (Basel, Switzerland) (2022)
sST2 definitely has the potential to provide information about the presence of PH in patients with severe AS, in a noninvasive way.